top of page
2025-01-17 App_907_2025
Source:
change in parties
-
Rule 102 – Referral to the panel, Rule 305 – Change in parties, Rule 306 – Consequences for the proceedings, Rule 310 – Death or demise of a party, Rule 312 – Transfer of the patent or patent application during proceedings, Rule 333 – Review of case management orders
-
The following text is not a complete transcript of the decision/order:
Local Division Munich
UPC_CFI_145/2024
UPC_CFI_146/2024
UPC_CFI_147/2024
UPC_CFI_148/2024
Procedural Order
of the Court of First Instance of the Unified Patent Court
Local Division Munich
issued on 17 January 2025
CLAIMANTS
1) Sanofi Mature IP
2) Sanofi Winthrop Industrie
3) Sanofi Winthrop Industrie as successor of Sanofi-Aventis France
(not a party in UPC_CFI 145/2024)
4) Sanofi-Aventis GmbH
5) Sanofi Belgium
6) Sanofi-Aventis Deutschland GmbH
7) Sanofi S.r.l.
8) Sanofi B.V.
9) Sanofi - Produtos Farmaceuticos Lda
10) Sanofi AB
11) Sanofi A/S
represented by: Frédéric Chevallier (Herbert Smith Freehills).
DEFENDANTS – UPC_CFI_145/2024
1) Accord Healthcare S.L.U.
2) Accord Healthcare GmbH (AT)
3) Accord Healthcare BV
4) Accord Healthcare GmbH (DE)
5) Accord Healthcare Italia Srl
6) Accord Healthcare B.V.
7) Accord Healthcare, Unipessoal Lda.
8) Accord Healthcare AB
represented by: Jules Fabre, Arjan Reijns, Louise Millot (Pinsent Mason).
DEFENDANTS – UPC_CFI_146/2024
1) STADAPHARM GmbH
2) STADA Arzneimittel AG
3) STADA Nordic ApS
represented by: Daniel Hoppe (Bonabry).
DEFENDANTS – UPC_CFI_147/2024
1) Reddy Pharma SAS
2) betapharm Arzneimittel GmbH
3) Dr Reddy's Srl
represented by: Dr. Christian Meyer (Maiwald)
Dr. Andreas Ledl (Maiwald).
DEFENDANTS – UPC_CFI_148/2024
1) Zentiva France
2) Zentiva Pharma GmbH
3) Zentiva, k.s.
represented by: Dr. Anja Lunze (Taylor Wessing)
Dr. Elisabeth Greiner (df-mp).
PATENT AT ISSUE
European patent n° 2 493 466
PANEL/DIVISION
Panel 1 of the Local Division Munich
DECIDING JUDGE/S
This order has been issued by the Presiding Judge Dr. Matthias Zigann acting as judge-
rapporteur.
LANGUAGE OF THE PROCEEDINGS
English
SUBJECT-MATTER OF THE PROCEEDINGS
Patent infringement – R 305 RoP regarding Sanofi Mature IP in UPC_CFI_145/2024,
UPC_CFI_146/2024, UPC_CFI_147/2024 and UPC_CFI_148/2024
REQUESTS BY THE PARTIES
Sanofi requests in APP_907/2025, 1181/2025, 1192/2025, 1193/2025, 1194/2025,
1195/2025, 1197/2025 and 1199/2025 regarding the four infringement actions and the
four counterclaims:
- Order that Sanofi SA be added as a party in the present action and all related proceedings;
- Sanofi Mature IP be substituted by Sanofi SA in the present action and all related
proceedings;
- Order that Sanofi SA takes over the proceedings as the new proprietor of the patent EP 466
in suit; and
- Order that this substitution of parties has no consequence on the proceedings within the
meaning of Rules 306 and 310 RoP, as Sanofi SA resumes all rights and obligations of Sanofi
Mature IP which has ceased to exist.
LEGAL ISSUES
Sanofi argues:
Sanofi Mature IP was the patent holder of EP 466 when it initiated the infringement actions,
and Sanofi Mature IP was the named defendant in the related revocation counterclaims. On
29 September 2024, the Sanofi group reorganized its group of companies, and Sanofi Mature
IP has been dissolved without liquidation as all the shares of Sanofi Mature IP came to be
held by its single shareholder, Sanofi SA. This resulted in the universal transfer of assets of
Sanofi Mature IP to Sanofi SA, including the ownership of EP 466.
As a consequence, on the basis of Rules 305(1), 312(1) and (2) RoP, the Claimants request
from the Court that (i) Sanofi SA be added as a party, (ii) Sanofi Mature IP be substituted by
Sanofi SA in the present action and all related proceedings, (iii) it authorizes Sanofi SA, as the
new proprietor, to be added as a party and substituted to Sanofi Mature IP as the patent and
the claims have been assigned to Sanofi SA, and (iv) it authorises Sanofi SA as "the new
proprietor tak[ing] over the proceedings" such that "no new court fee shall be payable". For
the sake of clarity, the new proprietor, Sanofi SA, is represented by the same representative
as Sanofi Mature IP(and all other Claimants for that matter). This substitution of parties has
no consequence on the proceedings within the meaning of Rules 306 and 310 RoP, as Sanofi
SA resumes all rights and obligations of Sanofi Mature IP which has ceased to exist as a
consequence of its dissolution without liquidation.
GROUNDS
The defendants were heard at the oral argument hearing (" preliminary interim conference ")
on 15 January 2025. They raised no objections. The Court also has no objections. Sanofi
Mature IP will therefore be replaced by Sanofi SA in the present and all related proceedings.
ORDER
1. Sanofi Mature IP is to be substituted by Sanofi SA in the present action and all
related proceedings.
2. Claimant No. 1 shall be designated “Sanofi SA as successor of Sanofi Mature IP “.
3. This replacement of parties has no consequence on the proceedings within the
meaning of Rules 306 and 310 RoP. Sanofi SA as successor of Sanofi Mature IP is
bound by the proceedings as now constituted.
INFORMATION ABOUT REVIEW BY PANEL
Any party may request that this Order be referred to the panel for a review pursuant
to R. 333 RoP. Pending review, the Order shall be effective (R. 102.2 RoP).
Instructions to the Parties and the Registry
1. Claimant No. 1 shall be designated “Sanofi SA as successor of Sanofi Mature IP “.
2. It may be impossible to implement this change in the old CMS. However, this
order takes precedence.
DETAILS OF THE ORDER
Order no. ORD_2029/2025 in ACTION NUMBER: ACT_16112/2024
UPC number: UPC_CFI_145/2024
Action type: Infringement Action
Related proceeding no. Application No.: 907/2025
Application Type: Application for a change in parties
Order no. ORD_2032/2025 in ACTION NUMBER: ACT_16112/2024
UPC number: UPC_CFI_463/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1199/2025
Application Type: Application for a change in parties
Order no. ORD_2034/2025 in ACTION NUMBER: ACT_16116/2024
UPC number: UPC_CFI_146/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1181/2025
Application Type: Application for a change in parties
Order no. ORD_2036/2025 in ACTION NUMBER: ACT_16116/2024
UPC number: UPC_CFI_496/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1194/2025
Application Type: Application for a change in parties
Order no. ORD_2037/2025 in ACTION NUMBER: ACT_16119/2024
UPC number: UPC_CFI_147/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1192/2025
Application Type: Application for a change in parties
Order no. ORD_2038/2025 in ACTION NUMBER: ACT_16119/2024
UPC number: UPC_CFI_374/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1195/2025
Application Type: Application for a change in parties
Order no. ORD_2039/2025 in ACTION NUMBER: ACT_16120/2024
UPC number: UPC_CFI_148/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1193/2025
Application Type: Application for a change in parties
Order no. ORD_2040/2025 in ACTION NUMBER: ACT_16120/2024
UPC number: UPC_CFI_503/2024
Action type: Infringement Action
Related proceeding no. Application No.: 1197/2025
Application Type: Application for a change in parties
bottom of page